These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Organizational and client determinants of cost in outpatient substance abuse treatment. Beaston-Blaakman A; Shepard D; Horgan C; Ritter G J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043 [TBL] [Abstract][Full Text] [Related]
7. Predictors of research use among staff in aboriginal addiction treatment programs serving women. Davey CJ; Niccols A; Henderson J; Dobbins M; Sword W; Dell C; Wylie T; Sauve E J Ethn Subst Abuse; 2014; 13(4):315-36. PubMed ID: 25397635 [TBL] [Abstract][Full Text] [Related]
8. Administrative burden and its implications for outpatient substance abuse treatment organizations. Lemak CH; Alexander JA; Campbell C Psychiatr Serv; 2003 May; 54(5):705-11. PubMed ID: 12719502 [TBL] [Abstract][Full Text] [Related]
9. The employment of nurses in publicly funded substance abuse treatment programs. Knudsen HK; Abraham AJ J Addict Nurs; 2012 Oct; 23(3):174-80. PubMed ID: 24135687 [TBL] [Abstract][Full Text] [Related]
10. Beliefs about evidence-based practices in addiction treatment: a survey of Veterans Administration program leaders. Willenbring ML; Kivlahan D; Kenny M; Grillo M; Hagedorn H; Postier A J Subst Abuse Treat; 2004 Mar; 26(2):79-85. PubMed ID: 15050084 [TBL] [Abstract][Full Text] [Related]
11. Client incentives versus contracting and staff incentives: how care continuity interventions in substance abuse treatment can improve residential to outpatient transition. Acquavita SP; Stershic S; Sharma R; Stitzer M J Subst Abuse Treat; 2013 Jul; 45(1):55-62. PubMed ID: 23375361 [TBL] [Abstract][Full Text] [Related]
12. Substance abuse treatment programs' data management capacity: an exploratory study. Wisdom JP; Ford JH; Wise M; Mackey D; Green CA J Behav Health Serv Res; 2011 Apr; 38(2):249-64. PubMed ID: 20574647 [TBL] [Abstract][Full Text] [Related]
13. Client and program characteristics associated with wait time to substance abuse treatment entry. Andrews CM; Shin HC; Marsh JC; Cao D Am J Drug Alcohol Abuse; 2013 Jan; 39(1):61-8. PubMed ID: 22783953 [TBL] [Abstract][Full Text] [Related]
14. Constructive conflict and staff consensus in substance abuse treatment. Melnick G; Wexler HK; Chaple M; Cleland CM J Subst Abuse Treat; 2009 Mar; 36(2):174-82. PubMed ID: 18657943 [TBL] [Abstract][Full Text] [Related]
15. Barriers to enrollment in drug abuse treatment and suggestions for reducing them: opinions of drug injecting street outreach clients and other system stakeholders. Appel PW; Ellison AA; Jansky HK; Oldak R Am J Drug Alcohol Abuse; 2004; 30(1):129-53. PubMed ID: 15083558 [TBL] [Abstract][Full Text] [Related]
16. The impact of managed care on publicly funded outpatient adolescent substance abuse treatment: service use and six-month outcomes in Oregon and Washington. Carlson MJ; Gabriel RM; Deck DD; Laws KE; D'Ambrosio R Med Care Res Rev; 2005 Jun; 62(3):320-38. PubMed ID: 15894707 [TBL] [Abstract][Full Text] [Related]
17. Two Models of Integrating Buprenorphine Treatment and Medical Staff within Formerly "Drug-Free" Outpatient Programs. Monico L; Schwartz RP; Gryczynski J; O'Grady KE; Mitchell SG J Psychoactive Drugs; 2016; 48(2):101-8. PubMed ID: 26940870 [TBL] [Abstract][Full Text] [Related]
19. Prevention validation and accounting platform: a framework for establishing accountability and performance measures of substance abuse prevention programs. Kim S; McLeod JH; Williams C; Hepler N J Drug Educ; 2000; 30(1):1-143. PubMed ID: 10893910 [TBL] [Abstract][Full Text] [Related]